Bill obtained his PhD in Organic Chemistry from Caltech. He is an organic and medicinal chemist with 15 years’ experience in research & development and drug discovery at GlaxoSmithKline (GSK).
[ a COI management plan oversees the complementary role Bill has as a member of the Board of Governors of Artisan Biopharma, cc-TDI’s wholly-owned public benefit corporation pediatric cancer biopharma. ]